Postoperative investigations in epilepsy surgery: Enzymes of the oxidative stress cascade, multi-druq transporters and transmitter receptors;Postoperative untersuchungen in der epilepsie-chirurgie: Enzyme der oxidativen stresskaskade, multi-drug-transporter und transmitterrezeptoren

Klinische Neurophysiologie

Volumn 33, Issue 3, 2002, Pages 168-177

  Bidmon, H J ^a   Palomero Gallagher, N ^b   Zilles, K ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Cerebral cortex; Epilepsy; Multi drug transporters; Oxidative stress; Transmitter receptors

Indexed keywords

AMPA RECEPTOR; CARRIER PROTEIN; CYCLOOXYGENASE 2; GLYCOPROTEIN P; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; EPILEPTIC DISCHARGE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SEIZURE; TEMPORAL LOBE EPILEPSY;

EID: 18744382465     PISSN: 14340275     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34829     Document Type: Article

References (45)

1. Treiman LJ, Treiman DM. Genetic aspects of epilepsy. In: Wyllie E (ed): The Treatment of Epilepsy. Philadelphia: Lippincott Williams & Wilkins, 2001: 115-129
2. Crino PB, Duhaime AC, Baltuch G, White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001; 56: 906-913
3. Zilles K, Qü MS, Köhling R, Speckmann E-J. Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: Quantitative in vitro receptor autoradiography. Neuroscience 1999; 94: 1051-1061
4. Shtilbans A, Shanske S, Goodman S, Sue CM, Bruno C, Johnson TL, Lava NS, Waheed N, DiMauro S. G8363A mutation in the mitochondrial DNA transfer ribonucleic acid Lys gene: Another cause of Leigh syndrome. J Child Neurol 2000; 15: 759-761
5. Blümcke I, Beck H, Lie AA, Wiestler OD. Molecular neuropathology of human mesial temporal lobe epilepsy. Epilepsy Res 1999; 36: 205-223
6. Speckmann E-J, Köhling R, Straub H, Wolf P, Ebner A, Tuxhorn I, Pannek HW, Rambeck B, Zilles K, Coenen HH, Löscher W. Perioperative untersuchungen in der epilepsiechirugie: Eine einführung. Klin Neurophysiol 2002; 33: 144-146
7. Bidmon HJ, Emde B, Kowalski T, Schmitt M, Mayer B, Kato K, Asayama K, Witte OW, Zilles K. Nitric oxide synthase-1 containing cortical interneurons co-express antioxidative enzymes and anti-apoptotic Bcl-2 following focal ischemia: Evidence for direct and indirect mechanisms towards their resistance to neuropathology. J Chem Neuroanat 2001; 22: 167-184
8. Celio MR, Spreafico R, de Biasi S, Vitellaro-Zuccarello L. Perineuronal nets: Past and present. Trends Neurosci 1998; 21: 510-515
9. Löscher W. Current status and future directions in pharmacotherapy of epilepsy. Trends Pharmacol Sci 2002; 23: 113-118
10. Judas M, Sestan N, Kostovic L. Nitrinergic neurons in the developing and adult human telencephalon: Transient and permanent patterns of expression in comparison to other mammals. Microsc Res Tech 1999; 45: 401-419
11. Kara P, Friedlander MJ. Dynamic modulation of cerebral cortex synaptic function by nitric oxide. Prog Brain Res 1998; 118: 183-198
12. th Meeting of the German Neuroscience Soc. Suttgart: Thieme, 2001; Vol. 11: 998
13. Wallace MN, Brown IE, Cox AT, Harper MS. Pyramidal neurons in human precentral gyrus contain nitric oxide synthase. Neuroreport 1995; 6: 2532-2536
14. Sohn YK, Ganju N, Bloch KD, Wands JR, de la Monte SM. Neuritic sprouting with aberrant expression of nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 1999; 162: 133-151
15. Lüth HJ, Holzer M, Gertz HJ, Arendt T. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. Brain Res 2000; 852: 45-55
16. Gonzalez-Hernandez T, Garcia-Marin V, Perez-Delgado MM, Gonzalez-Gonzalez ML, Rancel-Torres N, Gonzalez-Feria L. Nitric oxide synthase expression in the cerebral cortex of patients with epilepsy. Epilepsia 2000; 41: 1259-1268
17. Martin R, Gutierrez A, Penafiel A, Marin-Padilla M, de la Calle A. Persistence of Cajal-Retzius cells in the adult human cerebral cortex. An immunohistochemical study. Histol Histopathol 1999; 14: 487-490
18. Yermakova A, O'Banion MK. Cyclooxygenases in central nervous system: Implications for treatment of neurological disorders. Curr Pharmaceut Design 2000; 6: 1755-1776
19. O'Banion MK. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999; 13: 45-82
20. Bidmon H-J, Oermann E, Schiene K, Schmitt M, Kato K, Asayama K, Witte OW, Zilles K. Unilateral upregulation of cyclooxygenase-2 (COX-2) following cerebral, cortical photothrombosis in the rat: Suppression by MK-801 and co-distribution with enzymes involved in the oxidative stress cascade. J Chem Neuroanat 2000; 20: 163-176
21. Aoyama K, Matsubara K, Fujikawa Y, Nagahiro Y, Shimizu K, Umegae N, Hayase N, Shiono H, Kobayashi S. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases. Ann Neurol 2000; 47: 524-527
22. Estevez AG, Sampson JB, Zhuang YX, Spear N, Richardson GJ, Crow JP, Tarpey MM, Barbeito L, Beckman JS. Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. Free Radical Biol Med 2000; 28: 437-446
23. Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14085-14089
24. Kurazono S, Okamoto M, Sakiyama J, Mori S, Nakata Y, Fukuoka J, Amano S, Oohira A, Matsui H. Expression of brain specific chondroitin sulfate proteoglycans, neurocan and phosphacan, in the developing and adult hippocampus of Ihara's epileptic rats. Brain Res 2001; 898: 36-48
25. Härtig W, Derouiche A, Welt K, Brauer K, Grosche J, Mäder M, Reichenbach A, Brückner G. Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res 1999; 842: 15-29
26. Morris NP, Henderson Z. Perineuronal nets ensheath fast spiking, parvalbumin-immunoreactive neurons in the medial septum/diagonal band complex. Eur J Neurosci 2000; 12: 828-838
27. Potschka H, Fedrowitz M, Löscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001; 12: 3557-3560
28. Sisodiya SM, Heffernan J, Squier MV. Over-expression of P-glycoprotein in malformations of cortical development. Neuroreport 1999; 10: 3437-3441
29. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc Natl Acad Sci USA 1998; 95: 14482-14487
30. Rice AC, DeLorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 1998; 782: 240-247
31. 3+-induced epileptogenesis. Molecular Brain Res 2001; 92: 107-114
32. Ekonomou A, Smith AL, Angelatou F. Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced "kindling" model of epilepsy. Molecular Brain Res 2001; 95: 27-35
33. Okazaki MM, Nadler JV. Glutamate receptor involvement in dentate granule cell epileptiform activity evoked by mossy fiber stimulation. Brain Res 2001; 915: 58-69
34. Buchkremer-Ratzman I, August M, Hagemann G, Witte O. Electrophysiological transcortical diaschisis after cortical photothrombosis in rat brain. Stroke 1996; 27: 1105-1109
35. Luhmann HJ, Mittmann T, van Luijtelaar G, Heinemann U. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 1995; 22: 43-51
36. Joseph SA, Lynd-Balta E. Evidence for an anatomical substrate of hyperexcitability in human temporal lobe epilepsy: Glutamate receptor alterations and reorganized ciscuitry. Funct Neurol 2001; 16: 347-365
37. 11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001; 56: 897-906
38. Hammers A, Koepp MJ, Richardson MP, Labbé C, Brooks DJ, Cunningham VJ, Duncan JS. Central benzodiazepine receptors in malformations of cortical development. A quantitative study. Brain 2001; 124: 1555-1565
39. 11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997; 120: 1865-1876
40. 11C]Flumazenil positron emission tomography study. Epilepsia 1997; 38: 1089-1097
41. Crino PB, Duhaime A-C, Baltuch G, White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 2001; 56: 906-913
42. A receptor subunit mRNAs in hippocampal pyramidal and granular neurons in the kindling model of epileptogenesis: An In-situ hybridization study. Molec Brain Res 1995; 31: 33-47
43. 3H]glutamate binding in the epileptic rat hippocampus: An autoradiographic study. NeuroReport 1993; 4: 45-48
44. Köhling R, Qü M, Zilles K, Speckmann E-J. Current-source-density profiles associated with sharp waves in human epileptic neocortical tissue. Neuroscience 1999; 94: 1039-1050
45. Köhling R, Straub H, Speckmann E-J. Postoperative untersuchungen: Funktionelle analysen: Bioelektrische registrierungen mit konventionellen methoden und spannungsempfindlichen farbstoffen. Klin Neurophysiol 2002; 33: 163-167